MRIMath

MRIMath is a private medical AI and software company developing FDA-cleared and pipeline imaging tools for neuro-oncology and brain MRI workflow. Its core offering, MRIMath i 2Contour, is a cloud-based cyber device and AI solution for glioblastoma segmentation, volumetric measurement, and treatment-planning support. The company focuses on helping clinicians and researchers analyze brain tumor images faster and more consistently, with products spanning AI-based segmentation, smart manual contouring, uncertainty quantification, and collaborative image-sharing tools. MRIMath appears to operate at the intersection of medical device software, radiology workflow, and oncology decision support, with roots in academic research from Rowan University and the University of Alabama at Birmingham.